Evaluation of the QTc interval during lenvatinib treatment in radioiodine-refractory differentiated thyroid cancer: reports from the real-life clinical practice

Future Oncology, Ahead of Print.

Source: Future Oncology - August 15, 2019 Category: Cancer & Oncology Authors: Michela Marina Maria Francesca Serra Paolo Del Rio Graziano Ceresini Source Type: research